A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone-refractory prostate cancer. (Q48456368)
Jump to navigation
Jump to search
scientific article published in November 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone-refractory prostate cancer. |
scientific article published in November 2007 |
Statements
1 reference
A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone-refractory prostate cancer. (English)
1 reference
Fred Saad
1 reference
Michael A Carducci
1 reference
Per-Anders Abrahamsson
1 reference
David P Dearnaley
1 reference
Claude C Schulman
1 reference
Scott A North
1 reference
Darryl J Sleep
1 reference
Jeffrey D Isaacson
1 reference
Joel B Nelson
1 reference
Atrasentan Phase III Study Group Institutions
1 reference
1 November 2007
1 reference
1 reference
110
1 reference
1959-1966
1 reference
9
1 reference
1 reference
Identifiers
1 reference
1 reference